ArticleInternal medicine (Tokyo, Japan)2019

The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment.

Goki Suda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.